Familial Primary Pulmonary Hypertension
Familial Primary Pulmonary Hypertension
Explore linked clinical trials. Standard reference: MESH:M055152419 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | Familial Primary Pulmonary Hypertension, Skin and Connective Tissue Diseases, cardiovascular disorder, connective tissue disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Enrolling by invitation | Phase 3 | 2026-10-06 | NCT03683186 | |
| : Vascular Function in Health and Disease | Chronic Disease, Disease Attributes, Familial Primary Pulmonary Hypertension, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, chronic obstructive pulmonary disease, heart disorder, heart failure, hypertensive disorder, lung disorder, obstructive lung disease, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 1 | 2026-09-25 | NCT02966665 | |
| Hormonal, Metabolic, and Signaling Interactions in PAH | Familial Primary Pulmonary Hypertension, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Not stated | 2026-09-25 | NCT01884051 | |
| Right Ventricular Pacing in Pulmonary Arterial Hypertension | Familial Primary Pulmonary Hypertension, Ventricular Dysfunction, Ventricular Dysfunction, Right, cardiovascular disorder, heart disorder, lung disorder, pulmonary hypertension, respiratory system disorder | Recruiting | Not applicable | 2026-09-02 | NCT04194632 | |
| Sotatercept in Pulmonary Arterial Hypertension | Familial Primary Pulmonary Hypertension, lung disorder, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 4 | 2026-07-09 | NCT07140484 | |
| Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH) | Familial Primary Pulmonary Hypertension, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary hypertension, respiratory system disorder | Recruiting | Not stated | 2026-05-29 | NCT05462574 | |
| Efficacy and Safety of Qishen Yiqi Dropping Pills in Patients With Severe Pulmonary Hypertension | Familial Primary Pulmonary Hypertension, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary hypertension, respiratory system disorder | Recruiting | Not applicable | 2026-05-22 | NCT07604805 | |
| Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled Trial | Familial Primary Pulmonary Hypertension, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary hypertension, respiratory system disorder | Enrolling by invitation | Not applicable | 2026-04-30 | NCT07558460 | |
| EVE TRIAL , ALMA SYSTAM | Familial Primary Pulmonary Hypertension, Female Urogenital Diseases and Pregnancy Complications, Hemorrhage, Obstetric Labor Complications, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postpartum Hemorrhage, Urogenital Diseases, Uterine Hemorrhage, lung disorder, pregnancy disorder, puerperal disorder, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 3 | 2026-03-30 | NCT06646653 | |
| Endothelial Cell Activation and Total Pulmonary Resistance in PAH | Familial Primary Pulmonary Hypertension, lung disorder, pulmonary hypertension, respiratory system disorder | Not yet recruiting | Not applicable | 2026-03-25 | NCT06035861 | |
| Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals | Familial Primary Pulmonary Hypertension, cardiovascular disorder, hypertensive disorder, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2026-03-10 | NCT05584722 | |
| 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH) | Familial Primary Pulmonary Hypertension, Skin and Connective Tissue Diseases, connective tissue disorder, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 2 | 2026-02-24 | NCT06104228 | |
| Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Familial Primary Pulmonary Hypertension, Hernia, Hernia, Diaphragmatic, Internal Hernia, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, congenital diaphragmatic hernia, lung disorder, pulmonary hypertension, pulmonary hypoplasia, respiratory system disorder | Recruiting | Not applicable | 2026-02-23 | NCT03138863 | |
| Pulmonary Hypertension Biorepository and Registry | Familial Primary Pulmonary Hypertension, Hypoxia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, cardiovascular disorder, chronic thromboembolic pulmonary hypertension, congenital generalized lipodystrophy type 3, hypertensive disorder, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, pulmonary hypertension, primary, 2, pulmonary hypertension, primary, 3, pulmonary hypertension, primary, 4, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2025-08-01 | NCT04808596 | |
| Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil | Familial Primary Pulmonary Hypertension, Skin and Connective Tissue Diseases, connective tissue disorder, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 3 | 2025-01-29 | NCT03992755 | |
| Non-Invasive Measurements of Changes in Pulmonary Artery Pressure in Intensive Care Unit Patients Using Electrical Impedance Tomography - A Feasibility Study | Familial Primary Pulmonary Hypertension, lung disorder, pulmonary hypertension, respiratory system disorder | Recruiting | Not stated | 2024-11-14 | NCT06544148 | |
| Potts-shunt for the Treatment of Pediatric Patients With Severe Pulmonary Hypertension | Familial Primary Pulmonary Hypertension, lung disorder, pulmonary hypertension, respiratory system disorder | Recruiting | Not applicable | 2024-05-28 | NCT06429579 | |
| REstoration of VItamin D in Pulmonary Arterial Hypertension | Familial Primary Pulmonary Hypertension, Nutritional and Metabolic Diseases, lung disorder, nutritional deficiency disease, nutritional disorder, pulmonary hypertension, respiratory system disorder, vitamin D deficiency, vitamin deficiency disorder | Not yet recruiting | Phase 4 | 2024-02-14 | NCT06258850 | |
| Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension | Familial Primary Pulmonary Hypertension, cardiovascular disorder, chronic thromboembolic pulmonary hypertension, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Enrolling by invitation | Not stated | 2022-05-19 | NCT03388476 |